Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Mirin

😃Good
Catalog No. T60273Cas No. 299953-00-7
Alias 5-(4-Hydroxybenzylidene)-2-iminothiazolidin-4-one

Mirin is a Mre11-Rad50-Nbs1 (MRN) complex inhibitor that inhibits MRN-dependent ATM activation without affecting ATM protein kinase activity. It also inhibits Mre11-associated exonuclease activity, thereby disrupting DNA double-strand break repair.Mirin induces cell cycle arrest in G1 phase.

Mirin

Mirin

😃Good
Purity: 99.24%
Catalog No. T60273Alias 5-(4-Hydroxybenzylidene)-2-iminothiazolidin-4-oneCas No. 299953-00-7
Mirin is a Mre11-Rad50-Nbs1 (MRN) complex inhibitor that inhibits MRN-dependent ATM activation without affecting ATM protein kinase activity. It also inhibits Mre11-associated exonuclease activity, thereby disrupting DNA double-strand break repair.Mirin induces cell cycle arrest in G1 phase.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$30In StockIn Stock
5 mg$40In StockIn Stock
10 mg$65In StockIn Stock
25 mg$121In StockIn Stock
50 mg$180-In Stock
100 mg$265-In Stock
200 mg$392-In Stock
1 mL x 10 mM (in DMSO)$44In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.24%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Mirin is a Mre11-Rad50-Nbs1 (MRN) complex inhibitor that inhibits MRN-dependent ATM activation without affecting ATM protein kinase activity. It also inhibits Mre11-associated exonuclease activity, thereby disrupting DNA double-strand break repair.Mirin induces cell cycle arrest in G1 phase.
In vitro
Mirin inhibits H2AX phosphorylation with an IC5​​0 value of 66 μM.
Mirin inhibits ATM-dependent phosphorylation of downstream targets Nbs1 and Chk2 as well as MRN-dependent ATM autophosphorylation at Ser1981 in response to DSBs.
Mirin treatment (50, 100 μM) of TOSA4 cells induced a significant G2 arrest.
Mirin (10-100 μM) inhibits homology-dependent DNA repair in TOSA4 cells. [1]
Synonyms5-(4-Hydroxybenzylidene)-2-iminothiazolidin-4-one
Chemical Properties
Molecular Weight220.25
FormulaC10H8N2O2S
Cas No.299953-00-7
SmilesO=C1N=C(SC1=CC2=CC=C(O)C=C2)N
Storage & Solubility Information
Storagekeep away from direct sunlight,keep away from moisture | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMF: 60 mg/mL (272.42 mM), Sonication is recommended.
Solution Preparation Table
DMF
1mg5mg10mg50mg
1 mM4.5403 mL22.7015 mL45.4030 mL227.0148 mL
5 mM0.9081 mL4.5403 mL9.0806 mL45.4030 mL
10 mM0.4540 mL2.2701 mL4.5403 mL22.7015 mL
20 mM0.2270 mL1.1351 mL2.2701 mL11.3507 mL
50 mM0.0908 mL0.4540 mL0.9081 mL4.5403 mL
100 mM0.0454 mL0.2270 mL0.4540 mL2.2701 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy Mirin | purchase Mirin | Mirin cost | order Mirin | Mirin chemical structure | Mirin in vitro | Mirin formula | Mirin molecular weight